The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
No source and nothing official just my view and conviction from past experiences. May agree or disagree but the SP is reflecting this state of affairs. A steady non-covid alternative source of revenue is needed.
DHSC will not be resolved anytime soon. And when it is no guarantee it will be favourable. Premature talk of a takeover and basically not in NOVACYT shareholders interest as it will reflect the residual cash after dispute ruling and a very modest premium. This company has lost its shine and in my view performance will be mediocre. A catalyst is needed to revive SP in a tangible way but honestly i cannot see any on the horizon.
SP at 3p very possible in this scenario if no news forthcoming. Market hates a void in news flows. Seen it all before nothing new. I am willing to hold but i am fully aware of risk that tox results will not be as good as expected or further trial delays which would torpedo the price. Obviously a result to the contrary would make me and fellow investors very very happy. Just be aware of the risks.
Much more Pav5.. Trial delays or a hefty rights issue possible two scenarios.
Point taken Working. Yes bought in two batches last year. I believe in the research too and that,s why i am holding but still feet on the ground.
Because of the importance of those results and the expectation that the announcement is expected relatively soon , the outcome would in my view have a bearing on the SP direction. I am a holder at average 2p price .
Apart from annoying , it also shows the uncertainty of the outcome of the toxic results. That's was always the initial risk which is part and parcel of the sector.
Grim Tim, i follow your reasoning. But apart from the mathematics the market is always forward looking and therefore more interested in the company's plans post covid which at the moment are just vague talk.
"playing a game of poker using our money" Not OK with that at all Potnak. I do not have pleasant experiences of consolidations.I feel something sinister in this decision.
Potnak, you are refreshingly level headed and consistent in your reasoning. Thank you. Indeed there are risks and i am taking a medium term view and not expecting any tangible developments any time soon. I doubt whether there is any possibility of a take out at this stage.
Good observation 37pits. Chance of further delays very real. Hope not.
BIXY , forget communication with SH. This CEO will still be finding his feet after another year and when he does he will realise he is barefoot. No catalyst for SP and therefore only way is painfully down. I honestly had been hoping to buy but have now changed my mind and thankful i did not fall into the trap laid by the irresponsible rampers.
Yes interested in ODX for one penny. No added value.
Pebble the increase in cases seems irrelevant to Novacyts cause. Govt has set the pace of " living with Covid" . Fact is that unless NCYT comes up with something unique and innovative the SP will simply be eaten away. The 100m is a buffer but really can be reduced substantially with Staff and R & D costs together with DHSC dispute costs/decision. The Gold Standard product that was hailed has fallen into oblivion. Talk of a bid are just fantasy at this stage. The CEO does not inspire confidence at all with his blabber and vague talk.
Hans... you can agree to disagree but everyone free to express opinion. Investors lost a lot of money being influenced by irresponsible rampers who have now vanished from the scene at their expense. There is now , in my view, no immediate catalyst to justify buying the share. Vague CEO talk is not enough and the market is not at all impressed with money at the Bank.
Thanks Archy. Fully support your view. You have the guts and good sense to call a spade a spade. NCYT is like a falling knife. CEO statement is just words without any tangible backing. Lots of generic statements .Investor interest has been shaken and lost.
With due respect Celtic, how would you know that the tox results " will be very good"
John , the SP has not gone down only because of the DHSC dispute but more the cause of lack of complete confidence and conviction that Nova can raise funds from non covid revenues . The CEO interview is testimony of this. Lots of talk but very little substance and direction.
Aber, forget about any offer for SAR at this stage. Too many question marks and delays will persist.
What positive comments ? just a partial recoup of yesterday's loss. Downtrend still intact.